GE Healthcare is working with the University of Oxford-led National Consortium of Intelligent Medical Imaging (NCIMI) to develop and test algorithms to aid in the diagnosis and management of Covid-19 pneumonia.
The programme will focus on predicting, enhancing and testing potential algorithms to diagnose Covid-19 pneumonia and predict which patients will develop severe respiratory distress, and which patients might develop long-term lung function problems even after they recover.
Go deeper with GlobalData
Identification of the highest-risk patients could help physicians to accelerate intensive care support, while lower-risk patients could be discharged from hospital sooner.
GE Healthcare president and CEO Kieran Murphy said: “As health systems manage Covid-19 cases, clinicians can benefit from new technologies to help triage and determine which patients are likely to develop respiratory distress and longer-term complications. If we can ensure patients are quickly placed in the right care setting, this may help to improve outcomes.”
